Michael S. Perry, President & CMO at PONIARD PHARMACEUTICALS, INC. (PARD), sold 6,346 shares at $0.87 ($6K) on 2012-02-16, disclosed to the SEC on 2012-02-17.
Open-market sale of $6k PARD by President & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCEL | SELL | 2022-11-22 | $1.1M | — | Filing → |
| RCEL | SELL | 2022-02-25 | $189K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $460K | — | Filing → |